NCT06296966View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Dry Eye
Interventions
DRUG

VSJ-110

ophthalmic solution

DRUG

Placebo

ophthalmic solution

Trial Locations (1)

01810

RECRUITING

Vanda Investigational Site, Andover

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY